Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Cancer Res. 2011 Nov 11;72(1):165–175. doi: 10.1158/0008-5472.CAN-11-2552

Figure 1. Downregulation of p18INK4c at senescence.

Figure 1

A. HDFs (TIG3) were passaged continuously until they reached replicative senescence (Sen). Cell lysates prepared at the indicated population doublings (PD) were fractionated by SDS-PAGE and immunoblotted for p16INK4a, p21CIP1 and p18INK4c. Right panel shows a direct comparison between proliferating (P) and senescent (S) cells. B. HDFs (TIG3) were infected with a retrovirus encoding H-RASG12V or the empty vector control (Vec). Following drug selection, the levels of p18INK4c and p16INK4a were assessed by immunoblotting. C. Primary MEFs were infected with a retrovirus encoding H-RASG12V or the empty vector control (Vec). The levels of p18Ink4c and p16Ink4a were assessed by immunoblotting. D. HDFs (Hs68) were infected with a retrovirus encoding HA-tagged p16INK4a. The levels of p18INK4c and p16INK4a were assessed by immunoblotting. E. MG132 had no effect on p18INK4c levels in cells transduced with HA-p16INK4a or empty vector. F. The Leiden strain of p16INK4a-deficient fibroblasts were passaged until they reached senescence. Samples taken at the indicated PDs were immunoblotted for p18INK4c, with CDK4 as a loading control.

HHS Vulnerability Disclosure